GlaxoSmithKline Pharmaceuticals Limited — Board Meeting, 02-03-2026: Outcome of Board Meeting
02-03-2026 | 12:18 pm
02-03-2026 | 12:18 pm
GlaxoSmithKline Pharma's board has appointed Ronojit Biswas as Whole-Time Director & CFO for 3 years, effective April 1, 2026. Current CFO Juby Chandy moves to a new GSK Group role, stepping down March 11.
No comments yet. Be the first to comment!
All announcements from GlaxoSmithKline Pharmaceuticals Limited
